← FDA DRUG APPROVALS

FDA ANDA · ANDA075151

MAGNESIUM SULFATE

Sponsor: HOSPIRA

APPLICATION
ANDA075151
TYPE
ANDA
ORIGINAL APPROVAL
2000-04-25
LATEST ACTION
2019-11-26
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INTRAMUSCULAR, INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

MAGNESIUM SULFATEPrescription
MAGNESIUM SULFATE 5GM/10ML (500MG/ML) · SOLUTION · INTRAMUSCULAR, INTRAVENOUS

Approval history

2019-11-26Labeling · Supplement 15 · standardAP
2015-10-26Labeling · Supplement 13 · standardAP
2012-12-17Manufacturing (CMC) · Supplement 11AP
2004-08-23Labeling · Supplement 2AP
2000-04-25OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →